Mode
Text Size
Log in / Sign up
N/A N=30 Prevention

Happy Older Latinos Are Active - Cognitive Decline

Cognitive Decline

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Percentage of Participants Completing the Study — 90 Percentage of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Happy Older Latinos are Active (HOLA) (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
University of Miami
Primary completion
Mar 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Completing the Study
90
SECONDARY
Changes in Neurocognitive Impairment as Measured by the Trails Making Test
48.7; 172.0; 44.3; 137.0
SECONDARY
Changes in Neurocognitive Impairment as Measured by the WAIS-IV Digit Span
6.5; 6.81
SECONDARY
Changes in Physical Activity as Measured by the Global Physical Activity Questionnaire (GPAQ)
1,743; 4,533
SECONDARY
Changes in Depression as Measured by the PHQ-9
6.67; 4.26
SECONDARY
Changes in Anxiety as Measured by the GAD-7
4.83; 3.56
SECONDARY
Changes in Psychosocial Functioning as Measured by the MSPSS
5; 5
SECONDARY
Changes in Biomarkers of Cognition
6.6; 6.6; 3117.1; 3411.3; 34.1; 32.3
SECONDARY
Changes in Biomarkers of Cognition Levels
39.9; 36.6; 79.4; 65.8
SECONDARY
Changes in Adiponectin
13999.1; 14289.6

Summary

The purpose of this study is to look at the best ways to prevent cognitive decline (loss of memory and/or functioning) in midlife and older Latino adults living with HIV.

Eligibility Criteria

Inclusion Criteria

  • are Latino (self-identified);
  • are age 50+;
  • are HIV infected but are virologically suppressed (viral load <200 copies/mL);
  • volunteer informed consent

Exclusion Criteria

  • have diagnosis of any neurodegenerative disorder or dementia (Parkinson's disease, Alzheimer's disease, vascular, frontotemporal dementia, etc.) or significant cognitive impairment as indicated by a Telephone Interview for Cognitive Status (TICS) score less than or equal to 30;
  • have other conditions that could impact cognitive functioning or testing (e.g., legally blind or deaf), currently undergoing radiation or chemotherapy, a history of brain trauma with a loss of consciousness greater than 30 minutes.
  • have contraindications to physical activity outlined in the American College of Sports Medicine standards or severe medical illness that precludes them from safely participating in a health promotion intervention.
  • are unable to complete 10-meter walk test.
  • have plans to move outside of the Miami metropolitan area within the next 6 months or are not living in stable housing (e.g. group home).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04791709). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search